Toxicity of Cetuximab, Paclitaxel, Cisplatin and Concurrent Radiation in Chinese Patients with Locally Advanced Esophageal Squamous Cell Carcinoma: An Open-label, Multicenter Phase II Study

被引：0
|
作者：
Yu, J. [1 ]
Wang, J. [2 ]
Sun, X. [1 ]
Wang, L. [3 ]
Ye, M. [4 ]
Feng, P. [5 ]
Zhu, G. [6 ]
Lu, Y. [7 ]
Zhu, S. [8 ]
Liao, Z. [9 ]
机构：
[1] Shandong Canc Hosp, Jinan 250117, Shandong, Peoples R China
[2] Zhengzhou Univ, Canc Hosp, Jinan 250117, Shandong, Peoples R China
[3] Chinese Acad Med Sci, Peking Union Med Coll, Canc Hosp, Beijing 100730, Peoples R China
[4] Shanghai Jiao Tong Univ, Renji Hosp, Shanghai 200030, Peoples R China
[5] Jiangsu Canc Hosp, Nanjing, Peoples R China
[6] Peking Univ, Sch Oncol, Beijing Canc Hosp, Beijing 100871, Peoples R China
[7] Sichuan Univ, W China Hosp, W China Sch Med, Chengdu 610064, Peoples R China
[8] Hebei Med Univ, Hosp 4, Shijiazhuang, Peoples R China
[9] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2011年 / 81卷 / 02期
关键词：
D O I：
10.1016/j.ijrobp.2011.06.512
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S315 / S316
页数：2
相关论文
共 50 条
  • [41] Pembrolizumab for locally advanced and recurrent/metastatic cutaneous squamous cell carcinoma (KEYNOTE-629 study): an open-label, nonrandomized, multicenter, phase II trial
    Hughes, B. G. M.
    Munoz-Couselo, E.
    Mortier, L.
    Bratland, A.
    Gutzmer, R.
    Roshdy, O.
    Mendoza, R. Gonzalez
    Schachter, J.
    Arance, A.
    Grange, F.
    Meyer, N.
    Joshi, A.
    Billan, S.
    Zhang, P.
    Gumuscu, B.
    Swaby, R. F.
    Grob, J. -j.
    ANNALS OF ONCOLOGY, 2021, 32 (10) : 1276 - 1285
  • [42] A randomized, multicenter, open phase II study of cetuximab with docetaxel, cisplatin as induction chemotherapy in unresectable, locally advanced head and neck squamous cell carcinoma (LA-HNSCC)
    Koh, Youngil
    Lee, Keun-Wook
    Kim, Sung-Bae
    Park, Kyong Hwa
    Shin, Sang Won
    Kang, Jin Hyoung
    Keam, Bhumsuk
    Lee, Se-Hoon
    Heo, Dae Seog
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [43] A Phase 2 Trial of Induction nab-Paclitaxel and Cetuximab Given With Cisplatin and 5-Fluorouracil Followed by Concurrent Cisplatin and Radiation for Locally Advanced Squamous Cell Carcinoma of the Head and Neck
    Adkins, Douglas
    Ley, Jessica
    Trinkaus, Kathryn
    Thorstad, Wade
    Lewis, James, Jr.
    Wildes, Tanya
    Siegel, Barry A.
    Dehdashti, Farrokh
    Gay, Hiram
    Mehan, Paul
    Nussenbaum, Brian
    CANCER, 2013, 119 (04) : 766 - 773
  • [44] Paclitaxel and cisplatin combined with anlotinib as first line regimen for advanced esophageal squamous cell carcinoma (ESCC): A single-arm, multicentre open-label phase II clinical trial
    Wang, J-S.
    Wu, T.
    Hong, Y-G.
    Guo, Y-Z.
    Luo, S-X.
    Li, N.
    Cheng, Y-F.
    Li, B-S.
    ANNALS OF ONCOLOGY, 2020, 31 : S910 - S911
  • [45] ATLAS: A Phase II, open-label study of rucaparib in patients with locally advanced or metastatic urothelial carcinoma
    Grivas, Petros
    Teo, Min Yuen
    Vogelzang, Nicholas
    Alva, Ajjai
    Zakharia, Yousef
    Adra, Nabil
    Drakaki, Alexandra
    Hussain, Arif
    Morales-Barrera, Rafael
    Necchi, Andrea
    Rodriguez-Vida, Alejo
    Feyerabend, Susan
    Gupta, Sumati
    Josephs, Debra H.
    Loriot, Yohann
    Srinivas, Sandy
    Wride, Kenton
    Thomas, Daleen
    Dusek, Rachel
    Simmons, Andrew D.
    Nepert, Dale
    Chowdhury, Simon
    CANCER RESEARCH, 2019, 79 (13)
  • [46] Perioperative adebrelimab combined with chemotherapy for locally advanced resectable esophageal squamous cell carcinoma: A single-arm, open-label, multicenter study.
    Dai, Liang
    Wu, Yaya
    Tian, Ziqiang
    Ma, Jianqun
    Zhao, Changhong
    Zhuang, Bo
    Chen, Keneng
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL)
  • [47] Efficacy and safety of cisplatin combined with paclitaxel concurrent radiotherapy in patients with locally advanced cervical squamous cell carcinoma
    Feng, Tao
    Zhang, Yuxin
    Zheng, Guanghao
    Lv, Xiaojuan
    Yan, Dingding
    Feng, Yue
    Lou, Hanmei
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2025, 36 (01)
  • [48] Update results of paclitaxel and cisplatin in combination with anlotinib as first-line regimen for advanced esophageal squamous cell carcinoma (ESCC): A multicenter, single-arm, open-label phase II clinical trial.
    Wang Junsheng
    Luo Suxia
    Li Ning
    Wu Tao
    Hong Yonggui
    Guo Yanzhen
    Cheng Yufeng
    Li Baosheng
    Tan Bingxu
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (03)
  • [49] Phase II trial of concurrent bio-chemoradiotherapy using docetaxel, cisplatin, and cetuximab for locally advanced head and neck squamous cell carcinoma
    Nishimura, Goshi
    Taguchi, Takahide
    Takahashi, Masahiro
    Shiono, Osamu
    Komatsu, Masanori
    Sano, Daisuke
    Yabuki, Kenichiro
    Arai, Yasuhiro
    Takahashi, Hideaki
    Hata, Masaharu
    Oridate, Nobuhiko
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2016, 77 (06) : 1315 - 1319
  • [50] Phase II trial of concurrent bio-chemoradiotherapy using docetaxel, cisplatin, and cetuximab for locally advanced head and neck squamous cell carcinoma
    Goshi Nishimura
    Takahide Taguchi
    Masahiro Takahashi
    Osamu Shiono
    Masanori Komatsu
    Daisuke Sano
    Kenichiro Yabuki
    Yasuhiro Arai
    Hideaki Takahashi
    Masaharu Hata
    Nobuhiko Oridate
    Cancer Chemotherapy and Pharmacology, 2016, 77 : 1315 - 1319
12345